Biogen Inc (BSP:BIIB34)
R$ 169.49 1.36 (0.81%) Market Cap: 149.37 Bil Enterprise Value: 178.06 Bil PE Ratio: 15.80 PB Ratio: 1.56 GF Score: 75/100

Biogen Inc Annual Shareholders Meeting Transcript

Jun 19, 2019 / 01:00PM GMT
Release Date Price: R$147.62
Operator

Good morning, and welcome to the Biogen Inc. 2019 Annual Meeting of Stockholders. The meeting will now begin.

Stelios Papadopoulos
Biogen Inc. - Independent Chairman

Good morning. I'm Stelios Papadopoulos, and I'm the Chairman of the Board of Biogen. And I would like to welcome all of you to the 2019 Annual Stockholder Meeting of Biogen.

I'm here today with Susan Alexander on my left, Executive VP, Chief Legal Officer and Corporate Secretary of Biogen, who will act as Secretary of the meeting; and to my right, Michel Vounatsos, our Chief Executive Officer and (inaudible) who will make a company presentation following the conclusion of the formal portion of the meeting. I am also joined by each of the other members of our Board of Directors. I will name those later (inaudible) as well as members of the executive team of Biogen including Jeff Capello, Executive Vice President and Chief Financial Officer of the company; Michael Ehlers, Executive Vice President, Research and Development; Ginger Gregory, Executive Vice President, Human Resources

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot